Idiopathic guttate hypomelanosis: Presentation and Management. (17th February 2021)

• Record Type: Journal Article
• Authors: Buch, Jeta; Patil, Anant; Kroumpouzos, George; Kassir, Martin; Galadari, Hassan; Gold, Michael H.; Goldman, Mitchel P.; Grabbe, Stephan; Goldust, Mohamad
• Is Part Of: Journal of cosmetic and laser therapy. Volume 23:Number 1/2(2021)
• Page Start: 8
• Page End: 15
• Publication Date: 2021-02-17
• Subjects: Idiopathic guttate hypomelanosis -- etiology -- management -- treatment; Skin -- Laser surgery -- Periodicals; Surgery, Plastic -- Periodicals; 617.477
• DOI: 10.1080/14764172.2021.1957116
• Languages: English
• ISSNs: 1476-4172

Abstract

ABSTRACT: Idiopathic guttate hypomelanosis (IGH) is a benign, typically asymptomatic, acquired leukoderma characteristically affecting mature individuals. Although the etiopathogenesis is unclear, chronic sun exposure and senile degeneration are important triggers. Researchers have been engaged in a continuous effort to unveil the gray areas encompassing different aspects of IGH pathogenesis. IGH is a clinical diagnosis; however, histopathology and dermoscopy may aid in quetionable cases. Patients often seek cosmetic treatment. There has been no standard therapy for this condition. Newer treatment modalities range from topical agents to procedure-based therapies and have enhanced the therapeutic armamentarium. Here we discuss the pathogenesis, presentation, and management of IGH.